Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Hypertension

Free Subscription Articles published in JAMA Retrieve available abstracts of 69 articles: HTML format

Single Articles

January 2026
1. ANDERER S
   Combination Pills May Improve Hypertension.
   JAMA. 2026 Jan 23. doi: 10.1001/jama.2025.23034.
   PubMed    
   
   
   
2. JURASCHEK SP, Col H, Ferro K, Turkson-Ocran RN, et al
   DASH-Patterned Groceries and Effects on Blood Pressure: The GoFresh Randomized Clinical Trial.
   JAMA. 2026;335:36-48.
   PubMed     Abstract available
   
   
   December 2025
3. PANT S
   Chronic Pain Linked to Hypertension.
   JAMA. 2025 Dec 12. doi: 10.1001/jama.2025.20022.
   PubMed    
   
   
   
4. ANDERER S
   Hypertension Among Children Has Increased Significantly.
   JAMA. 2025 Dec 5. doi: 10.1001/jama.2025.20012.
   PubMed    
   
   
   November 2025
5. MAYA J, Pant D, Fu Y, James K, et al
   Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation.
   JAMA. 2025 Nov 24:e2520951. doi: 10.1001/jama.2025.20951.
   PubMed     Abstract available
   
   
   October 2025
6. TAI YH, Fu TC, Chang CM
   Lorundrostat for Uncontrolled Hypertension and Treatment-Resistant Hypertension.
   JAMA. 2025 Oct 22. doi: 10.1001/jama.2025.16167.
   PubMed    
   
   
   
7. SAXENA M, Rodman D
   Lorundrostat for Uncontrolled Hypertension and Treatment-Resistant Hypertension-Reply.
   JAMA. 2025 Oct 22. doi: 10.1001/jama.2025.16170.
   PubMed    
   
   
   September 2025
8. DESAI A, Havasi A, Saxena M
   Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension-Reply.
   JAMA. 2025 Sep 24. doi: 10.1001/jama.2025.13329.
   PubMed    
   
   
   
9. CHEN T, Zhu Z
   Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension.
   JAMA. 2025 Sep 24. doi: 10.1001/jama.2025.13326.
   PubMed    
   
   
   
10. ZHU J, Zhang W
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12790.
    PubMed    
    
    
    
11. GAO M, Cao T, Wu Q
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12787.
    PubMed    
    
    
    
12. GARRISON SR, Kolber MR, Korownyk CS
    Timing of Antihypertensive Medications and Cardiovascular Outcomes-Reply.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12796.
    PubMed    
    
    
    
13. CEDERNAES J, Benedict C
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12784.
    PubMed    
    
    
    
14. FENG S, Li H, Sun R
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12793.
    PubMed    
    
    
    
15. XU Q, Gao Y, Zhang O
    Medications for Resistant Hypertension.
    JAMA. 2025 Sep 15. doi: 10.1001/jama.2025.12653.
    PubMed    
    
    
    
16. BROOK RD, Cohen JB, Rajagopalan S
    Medications for Resistant Hypertension-Reply.
    JAMA. 2025 Sep 15. doi: 10.1001/jama.2025.12656.
    PubMed    
    
    
    
17. GAO M, Cao T, Wu Q
    Hypertension Medications and Health-Related Quality of Life.
    JAMA. 2025 Sep 10. doi: 10.1001/jama.2025.12228.
    PubMed    
    
    
    
18. LEE CJ, Kim DH, Park S
    Hypertension Medications and Health-Related Quality of Life-Reply.
    JAMA. 2025 Sep 10. doi: 10.1001/jama.2025.12231.
    PubMed    
    
    
    August 2025
19. ANDERER S, Rekito A
    Hypertension Survey Finds Many US Adults Lack Key Knowledge of the Condition.
    JAMA. 2025 Aug 15. doi: 10.1001/jama.2025.13589.
    PubMed    
    
    
    
20. SCHNEIDER L
    Medication Timing Could Influence Hypertension Treatment.
    JAMA. 2025 Aug 1. doi: 10.1001/jama.2025.10983.
    PubMed    
    
    
    June 2025
21. SAXENA M, Laffin L, Borghi C, Fernandez Fernandez B, et al
    Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial.
    JAMA. 2025 Jun 30:e259413. doi: 10.1001/jama.2025.9413.
    PubMed     Abstract available
    
    
    
22. ANDERER S
    Study Shows Decline in Hypertension Awareness Among US Adults.
    JAMA. 2025 Jun 27. doi: 10.1001/jama.2025.9633.
    PubMed    
    
    
    May 2025
23. DESAI AS, Karns AD, Badariene J, Aswad A, et al
    Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial.
    JAMA. 2025 May 28:e256681. doi: 10.1001/jama.2025.6681.
    PubMed     Abstract available
    
    
    
24. CHEBIB FT, Hanna C, Harris PC, Torres VE, et al
    Autosomal Dominant Polycystic Kidney Disease: A Review.
    JAMA. 2025;333:1708-1719.
    PubMed     Abstract available
    
    
    
25. LEE CJ, Ihm SH, Shin DH, Jeong JO, et al
    Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical Trial.
    JAMA. 2025 May 14:e255129. doi: 10.1001/jama.2025.5129.
    PubMed     Abstract available
    
    
    
26. BROOK RD, Cohen JB, Rajagopalan S
    New Support for Old Medications in Resistant Hypertension.
    JAMA. 2025 May 14. doi: 10.1001/jama.2025.4321.
    PubMed    
    
    
    
27. TALER SJ
    Morning or Nighttime Medication Dosing-Does It Matter in the Treatment of Hypertension?
    JAMA. 2025 May 12. doi: 10.1001/jama.2025.7286.
    PubMed    
    
    
    
28. GARRISON SR, Bakal JA, Kolber MR, Korownyk CS, et al
    Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial.
    JAMA. 2025 May 12:e254390. doi: 10.1001/jama.2025.4390.
    PubMed     Abstract available
    
    
    February 2025
29. ANDERER S
    Supine Hypertension Linked to Cardiovascular Risk Regardless of Seated Blood Pressure.
    JAMA. 2025 Feb 21. doi: 10.1001/jama.2025.0544.
    PubMed    
    
    
    January 2025
30. ANDERER S
    Hypertensive Disorders of Pregnancy May Be Associated With Future Neurological Issues.
    JAMA. 2025 Jan 24. doi: 10.1001/jama.2024.28057.
    PubMed    
    
    
    November 2024
31. GARG AX, Cuerden MS, Sontrop JM
    Hypertension Risk and Kidney Function Following Kidney Donation-Reply.
    JAMA. 2024 Nov 20. doi: 10.1001/jama.2024.21430.
    PubMed    
    
    
    
32. LIN Y, Huang J
    Hypertension Risk and Kidney Function Following Kidney Donation.
    JAMA. 2024 Nov 20. doi: 10.1001/jama.2024.21427.
    PubMed    
    
    
    
33. ZHONG P, Liu X, Liao L
    Hypertension Risk and Kidney Function Following Kidney Donation.
    JAMA. 2024 Nov 20. doi: 10.1001/jama.2024.21424.
    PubMed    
    
    
    October 2024
34. ANDERER S
    More Than Half of US Adults With Uncontrolled Hypertension Don't Know They Have It.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.20117.
    PubMed    
    
    
    
35. ABBASI J
    Semaglutide Updates, Hypertension Triple Pills, and More-Heart Health Highlights From ESC Congress.
    JAMA. 2024 Oct 4. doi: 10.1001/jama.2024.19544.
    PubMed    
    
    
    August 2024
36. OJJI DB, Salam A, Sani MU, Ogah OS, et al
    Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria: A Randomized Clinical Trial.
    JAMA. 2024 Aug 31. doi: 10.1001/jama.2024.18080.
    PubMed     Abstract available
    
    
    
37. MENSAH GA
    Is a Low-Dose Triple-Drug Combination Pill Protocol the Answer for Hypertension Control in Sub-Saharan Africa?
    JAMA. 2024 Aug 31. doi: 10.1001/jama.2024.18166.
    PubMed    
    
    
    July 2024
38. DIAO JA, Shi I, Murthy VL, Buckley TA, et al
    Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations.
    JAMA. 2024 Jul 29:e2412537. doi: 10.1001/jama.2024.12537.
    PubMed     Abstract available
    
    
    
39. HARRIS E
    Self-Monitoring and Managing Medications Improved High Blood Pressure.
    JAMA. 2024;332:7-8.
    PubMed    
    
    
    June 2024
40. BOCK A
    Antihypertensives Might Explain Some Older Adults' New Eczema Diagnoses.
    JAMA. 2024 Jun 21. doi: 10.1001/jama.2024.10347.
    PubMed    
    
    
    
41. HARRIS E
    Blood Pressure Drugs Linked to More Fractures, Falls in VA Nursing Homes.
    JAMA. 2024;331:1982.
    PubMed    
    
    
    
42. OGEDEGBE G, Teresi JA, Williams SK, Ogunlade A, et al
    Home Blood Pressure Telemonitoring and Nurse Case Management in Black and Hispanic Patients With Stroke: A Randomized Clinical Trial.
    JAMA. 2024 Jun 6. doi: 10.1001/jama.2024.6609.
    PubMed     Abstract available
    
    
    May 2024
43. HARRIS E
    Swapping Salt for a Substitute May Lower Deaths, Reduce Heart Problems.
    JAMA. 2024;331:1698-1699.
    PubMed    
    
    
    
44. GARG AX, Arnold JB, Cuerden MS, Dipchand C, et al
    Hypertension and Kidney Function After Living Kidney Donation.
    JAMA. 2024 May 23. doi: 10.1001/jama.2024.8523.
    PubMed     Abstract available
    
    
    April 2024
45. LI W
    Blood Pressure Self-Management After Hypertensive Pregnancy.
    JAMA. 2024;331:1156.
    PubMed    
    
    
    
46. KITT J, McManus RJ, Leeson P
    Blood Pressure Self-Management After Hypertensive Pregnancy-Reply.
    JAMA. 2024;331:1156-1157.
    PubMed    
    
    
    March 2024
47. HARRIS E
    Tirzepatide Lowered Blood Pressure in People With Obesity.
    JAMA. 2024;331:821.
    PubMed    
    
    
    
48. HARRIS E
    Weight Loss Surgery Managed Blood Pressure for People With Obesity.
    JAMA. 2024;331:725-726.
    PubMed    
    
    
    February 2024
49. ESTRADA RA, Auger WR, Sahay S
    Chronic Thromboembolic Pulmonary Hypertension.
    JAMA. 2024 Feb 26. doi: 10.1001/jama.2023.24265.
    PubMed    
    
    
    
50. SCHIFFRIN EL
    RNA Injection Every 6 Months to Improve Adherence and Lower Blood Pressure in Patients With Hypertension.
    JAMA. 2024 Feb 16. doi: 10.1001/jama.2023.26071.
    PubMed    
    
    
    
51. BAKRIS GL, Saxena M, Gupta A, Chalhoub F, et al
    RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.
    JAMA. 2024 Feb 16. doi: 10.1001/jama.2024.0728.
    PubMed     Abstract available
    
    
    
52. PALMA JA, Kaufmann H
    Pharmacologic Treatment for High BP and Risk of CVD.
    JAMA. 2024;331:530-531.
    PubMed    
    
    
    
53. JURASCHEK SP, Mukamal KJ
    Pharmacologic Treatment for High BP and Risk of CVD-Reply.
    JAMA. 2024;331:531-532.
    PubMed    
    
    
    November 2023
54. ELMALEH-SACHS A, Schwartz JL, Bramante CT, Nicklas JM, et al
    Obesity Management in Adults: A Review.
    JAMA. 2023;330:2000-2015.
    PubMed     Abstract available
    
    
    
55. HARRIS E
    Remote Hypertension Monitoring Improved Medication Use, Raised Costs.
    JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22936.
    PubMed    
    
    
    
56. KITT J, Fox R, Frost A, Shanyinde M, et al
    Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial.
    JAMA. 2023 Nov 11. doi: 10.1001/jama.2023.21523.
    PubMed     Abstract available
    
    
    
57. GUPTA DK, Lewis CE, Varady KA, Su YR, et al
    Effect of Dietary Sodium on Blood Pressure: A Crossover Trial.
    JAMA. 2023 Nov 11. doi: 10.1001/jama.2023.23651.
    PubMed     Abstract available
    
    
    October 2023
58. BYRD JB, Bisognano JD, Brook RD
    Treating Hypertension in Patients With Orthostatic Hypotension: Benefits vs Harms in the Era of Aggressive Blood Pressure Lowering.
    JAMA. 2023;330:1435-1436.
    PubMed    
    
    
    
59. JURASCHEK SP, Hu JR, Cluett JL, Ishak AM, et al
    Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
    JAMA. 2023;330:1459-1471.
    PubMed     Abstract available
    
    
    
60. HARRIS E
    Majority of People Live With Uncontrolled Hypertension Worldwide.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19204.
    PubMed    
    
    
    
61. SANCHEZ-DE-LA-TORRE M, Gracia-Lavedan E, Benitez ID, Sanchez-de-la-Torre A, et al
    Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis.
    JAMA. 2023;330:1255-1265.
    PubMed     Abstract available
    
    
    September 2023
62. DENOBLE AE, Pettker CM
    Hypertension Screening in Pregnancy: Remembering the Basics, Charting the Future.
    JAMA. 2023;330:1040-1041.
    PubMed    
    
    
    
63. HENDERSON JT, Webber EM, Thomas RG, Vesco KK, et al
    Screening for Hypertensive Disorders of Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;330:1083-1091.
    PubMed     Abstract available
    
    
    
64. BARRY MJ, Nicholson WK, Silverstein M, Cabana MD, et al
    Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement.
    JAMA. 2023;330:1074-1082.
    PubMed     Abstract available
    
    
    
65. JIN J
    Screening for High Blood Pressure Disorders During Pregnancy.
    JAMA. 2023;330:1107.
    PubMed    
    
    
    
66. WILLIAMS B
    A New Dawn for Aldosterone as a Therapeutic Target in Hypertension.
    JAMA. 2023 Sep 10. doi: 10.1001/jama.2023.17087.
    PubMed    
    
    
    
67. LAFFIN LJ, Rodman D, Luther JM, Vaidya A, et al
    Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial.
    JAMA. 2023 Sep 10:e2316029. doi: 10.1001/jama.2023.16029.
    PubMed     Abstract available
    
    
    
68. HARRIS E
    High Blood Pressure More Likely After COVID-19 Than Flu.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16676.
    PubMed    
    
    
    
69. MISTRY EA, Hart KW, Davis LT, Gao Y, et al
    Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke: The BEST-II Randomized Clinical Trial.
    JAMA. 2023;330:821-831.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.